Related Experiment Video
Updated: Jun 13, 2026
09:57
siRNA Transfection and EMSA Analyses on Freshly Isolated Human Villous Cytotrophoblasts
Published on: September 20, 2016
Proteases and sFlt-1 release in the human placenta
1Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Placenta
|May 4, 2010
Summary
Proteases like chymotrypsin-like serine protease and ADAM10 may increase soluble VEGF receptor-1 (sFlt-1) release in preeclampsia (PE) placentas. Inhibiting these proteases reduced sFlt-1 release in normal placenta tissue.
Area of Science:
- Reproductive Biology
- Biochemistry
- Pathophysiology
Background:
- Preeclampsia (PE) is linked to increased placental release of soluble VEGF receptor-1 (sFlt-1).
- The exact mechanisms driving elevated sFlt-1 in PE placentas remain unclear.
- Proteolytic activity is hypothesized to contribute to sFlt-1 release.
Purpose of the Study:
- To investigate the role of specific proteases in mediating sFlt-1 release from human placenta.
- To determine if protease inhibitors can reduce sFlt-1 release in placental tissue.
Main Methods:
- Human placental villous explants were treated with various protease inhibitors (serine, cysteine, metalloprotease inhibitors).
- Soluble VEGF receptor-1 (sFlt-1) levels in the culture medium were measured using ELISA.
- Immunohistochemistry was used to assess chymase and ADAM10 expression in normal and PE placental tissues.
Main Results:
- Treatment with chymotrypsin inhibitor (CI) and ADAM inhibitor (PTM) significantly reduced sFlt-1 release.
- Serine protease inhibitors (PMSF, aprotinin), cysteine protease inhibitor (E-64), and metalloendopeptidase inhibitor (PAD) had no significant effect.
- Chymase and ADAM10 expression were significantly elevated in the syncytiotrophoblast layer of PE placentas compared to normal placentas.
Conclusions:
- Chymotrypsin-like serine protease and ADAM10 are implicated in the increased placental sFlt-1 release observed in preeclampsia.
- Cysteine proteases and metalloendopeptidases do not appear to play a significant role in this process.
- Targeting chymotrypsin-like serine protease and ADAM10 may offer therapeutic strategies for preeclampsia.
Related Concept Videos
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...